Pura Vida Investments’s Medtronic MDT Stock Holding History

Pura Vida Investments’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-40,000	Closed	-$3.6M	–	36
2024 Q3	$3.6M	Buy	40,000 +10,000	+33%	+$841K	2.35%	20
2024 Q2	$2.36M	Buy	+30,000	New	+$2.46M	1.49%	24
2023 Q1	–	Sell	-130,000	Closed	-$10.1M	–	134
2022 Q4	$10.1M	Buy	+130,000	New	+$10.5M	0.52%	53
2022 Q3	–	Sell	-270,000	Closed	-$24.2M	–	234
2022 Q2	$24.2M	Sell	270,000 -90,000	-25%	-$9.12M	1.41%	15
2022 Q1	$39.9M	Buy	360,000 +35,000	+11%	+$3.7M	1.3%	18
2021 Q4	$33.6M	Buy	+325,000	New	+$37.6M	1.22%	15
2021 Q3	–	Sell	-500,000	Closed	-$62.1M	–	311
2021 Q2	$62.1M	Buy	500,000 +350,000	+233%	+$43.9M	1.93%	9
2021 Q1	$17.7M	Buy	+150,000	New	+$17.6M	0.5%	40
2020 Q3	–	Sell	-63,500	Closed	-$5.82M	–	168
2020 Q2	$5.82M	Buy	+63,500	New	+$6.09M	0.56%	44

Other funds holding MDT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Pura Vida Investments's MDT Position: Q4 2018 in Review

Pura Vida Investments sold out of Medtronic (MDT) in Q4 2018, closing a stake of 81,027 shares — an estimated $7.57M sold.

Pura Vida Investments first reported a position in MDT in Q2 2016 and held it in 5 quarters. The position peaked at $7.97M in Q3 2018. 1,564 funds tracked by Wall St. Rank hold MDT as of Q4 2018.

Pura Vida Investments reported no remaining Medtronic position as of Q4 2018 after selling out during the quarter.
Pura Vida Investments sold 81,027 Medtronic shares in Q4 2018, an estimated $7.57M.
Pura Vida Investments first reported a position in Medtronic in Q2 2016 and held it in 5 quarters.
Pura Vida Investments's Medtronic position peaked at $7.97M in Q3 2018.
1,564 funds tracked by Wall St. Rank held Medtronic as of Q4 2018.

Based on Pura Vida Investments's 13F filing for Q4 2018, filed 14 Feb 2019.